Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eva Tůmová
Observed names:
E Tůmová,
E. Tumova,
E. Tůmová,
Eva Tumova,
Tůmová, Eva
Institution:
Institute of Clinical and Experimental Medicine
Observed institutions:
Czech Academy of Sciences,
Charles University,
Institute of Clinical and Experimental Medicine,
General University Hospital in Prague,
Czech Academy of Sciences, Institute of Physiology
ORCID:
0000-0002-1588-0739
Observed ORCID:
0000-0002-1588-0739
OpenAlex ID:
A5102918232
Oxidative stress in the brain tissue of laboratory mice with acute post insulin hypoglycemia.
2003
·
J Patočková
, P Marhol
, et al.
·
Physiological Research
·
78
PDF
The Impact of Rapid Weight Loss on Oxidative Stress Markers and the Expression of the Metabolic Syndrome in Obese Individuals
2013
·
Eva Tumova
, Wensheng Sun
, et al.
·
Journal of Obesity
·
52
PDF
Cerebrolysin inhibits lipid peroxidation induced by insulin hypoglycemia in the brain and heart of mice
2003
·
J Patočková
, M Kršiak
, et al.
·
Physiological Research
·
33
PDF
Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?
2022
·
Michal Vrablik
, Alberto Corsini
, et al.
·
Current Atherosclerosis Reports
·
28
Body Adiposity Changes After Lifestyle Interventions in Children/Adolescents and the NYD-SP18 and TMEM18 Variants
2018
·
Lukas Zlatohlavek
, Vit Maratka
, et al.
·
Medical Science Monitor
·
7
PDF
Atherosclerosis and beta-blockade: A forgotten option?
2019
·
Michal Vrablík
, Eva Tůmová
·
Vnitřní lékařství
·
3
PDF
[Cholesterol metabolism in patients with type 2 diabetes].
2016
·
Michal Vrablík
, Eva Tůmová
·
PubMed
·
3
Importance of fixed-dose combinations in cardiovascular prevention: the possibility of treating two diagnoses with a single pill
2019
·
Eva Tůmová
, Michal Vrablík
·
Vnitřní lékařství
·
1
PDF
Arcus lipoides corneae
2013
·
Eva Tůmová
, Michal Vráblík
·
Medicína pro praxi
·
1
Atherosclerosis progression under the influence of subclinical inflammation
2025
·
Eva Tůmová
·
Vnitřní lékařství
PDF
Dyslipidemia and arterial hypertension: when to start intervention in primary prevention, use of vascular age
2022
·
Eva Tůmová
·
Medicína pro praxi
Correction to: Beta‑blockers for Atherosclerosis Prevention: a Missed Opportunity?
2022
·
Michal Vrablik
, Alberto Corsini
, et al.
·
Current Atherosclerosis Reports
PDF
Characteristics of patients with uncontrolled arterial hypertension and/or dyslipidemia – Lipitenclidec study
2021
·
M. Satny
, M. Vrablik
, et al.
·
Atherosclerosis
Současná intervence arteriální hypertenze a dyslipidemie
2021
·
Eva Tůmová
·
Medicína pro praxi
Clinical and laboratory characteristics of patients with uncontrolled dyslipidaemia and/or arterial hypertension in clinical practice in the Czech Republic
2020
·
M. Satny
, M. Snejdrlova
, et al.
·
Atherosclerosis
The Effectiveness Of Life-Style Counselling In Patients With Atherogenic Dyslipidemia On Lipid Profile And Atherosclerosis Risk
2019
·
E. Tůmová
, M. Šatný
, et al.
·
Atherosclerosis
Dyslipidemia Control In Primary Care In The Czech Republic
2019
·
M. Satny
, M. Vrablik
, et al.
·
Atherosclerosis
Familial dysbetalipoproteinemia – yes, or no? – Retrospective patient study of the center for preventive cardiology of the 3rd internal clinic first faculty of medicine and general university hospital
2018
·
M. Satny
, B. Grauova
, et al.
·
Atherosclerosis
Cardiovascular Risk Factors Control in Primary Care in the Czech Republic
2018
·
Martin Šatný
, Barbora Grauová
, et al.
·
Atherosclerosis Supplements
Combination therapy of risk factors of atherosclerosis in clinical practise
2017
·
Lukáš Zlatohlávek
, Eva Tůmová
, et al.
·
Medicína pro praxi
PDF
Emerging cardiovascular risk markers in diagnostics and therapy
2015
·
Tůmová, Eva
·
Digital Repository (National Repository of Grey Literature)
Show more works
View as search
Works count:
21
Citation count:
206
H-index:
5
I10-index:
4
Year
Topic
Type